Compazine iv pediatric

STUDY OBJECTIVE: We compare the effectiveness of intravenous ketorolac and intravenous prochlorperazine in the treatment of pediatric migraine headaches COMPAZINE. 3 brand of. 4 prochlorperazine. 5 antiemetic antipsychotic tranquilizer . Do not use in pediatric patients under 2 years of age or under 20 lbs

Compazine official prescribing information for healthcare professionals. was established in 4 week clinical studies of outpatients with generalized anxiety disorder. Do not use in pediatric patients under 2 years of age or under 20 lbs

7 Jul 2012 Prochlorperazine Edisylate (Compazine ). The authors make no claims of the accuracy of the information contained herein and these Clinical outcomes of children treated with intravenous prochlorperazine for with prochlorperazine used in children with severe migraine in a pediatric ED prochlorperazine (Rx) - Compazine, Compazine Spansules, AdultPediatric Geriatric IV: 2.5-10 mg q3-4hr not to exceed 10 mgdose or 40 mgday

Treatment of pediatric migraine headaches: a randomized, double

25 Jun 2014 Nausea (chemotherapy): 1.8 mgkg up to 100mg IVorally x 1. Children: 0.35 mgkg (maximum: 12.5 mg) as soon as needed .. Compazine Injection may be administered either undiluted (administered over 5 to 10 minutes) Detailed Compazine (prochlorperazine maleate) dosage and administration Non-Psychotic Anxiety Usual dosage is 5 mg 3 or 4 times daily. COMPAZINE (prochlorperazine maleate tablets USP) should not be used in pediatric patients

18 Dec 2014 Compazine 5-10 mg POIVIM q6-8 hours Compazine 25 mg PR q12 hours Sustained release Children (over age 2 years or gt10 kg) Compazine (prochlorperazine) is effective for the short-term treatment of established in 4-week clinical studies of outpatients with generalized anxiety disorder